ViaNautis Bio Appoints Dr. Adi Hoess as CEO to Propel Growth in Genetic Therapies

Cambridge, UK, October 18, 2024 (GlobeNewswire) -- ViaNautis Bio has appointed Dr. Adi Hoess as its new Chief Executive Officer, effective October 18, 2024, succeeding co-founder Dr. Francesca Crawford. Dr. Hoess brings over 13 years of leadership experience from Affimed N.V., where he successfully transitioned the company from an early-stage firm to a late-stage clinical powerhouse, securing multiple IND approvals and forging significant industry partnerships.

Read full article here.